Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study

The Journal of Clinical Endocrinology and Metabolism
K E FriendMichael O Thorner

Abstract

To determine if the mode of 17 beta-estradiol (E2) administration affects growth hormone (GH) concentrations, eight postmenopausal women were studied under the following conditions: (1) control (no E2), (2) oral E2 (Estrace, 1 mg every 12 h for 2 weeks) and (3) transdermal E2 (Estraderm patch, 0.1 mg, two patches changed daily for 2 weeks). Blood was collected every 5 min for 24 h and assayed for serum GH concentrations using a sensitive chemiluminescence assay. Serum E2 levels were comparable during both E2 treatment regimens when measured with a specific chemiluminescence assay. The 24-h integrated GH concentrations (IGHC, min . micrograms/L) increased in all eight subjects from (mean +/- SE) 494 +/- 102 during control to 860 +/- 111 (P < 0.05) and 832 +/- 149 (P < 0.05) during oral and transdermal E2, respectively. Both E2 treatments significantly increased GH pulse height, individual pulse area, incremental pulse amplitude, interpeak valley concentration, and interpeak valley nadir (as measured by Cluster algorithm) when compared with control. No significant differences were observed in the number of GH pulses per 24 h. Insulin-like growth factor-I (IGF-I, micrograms/L) concentrations decreased from 165 +/- 19 (control) to ...Continue Reading

Citations

Aug 18, 2012·International Journal of Endocrinology·Nigel Glynn, Amar Agha
May 1, 2008·The Journal of Clinical Endocrinology and Metabolism·Jean L ChanChristos S Mantzoros
Apr 11, 2008·Journal of Endocrinological Investigation·S L LauR Smith
Aug 4, 2005·Journal of Endocrinological Investigation·I IwamotoT Douchi
Dec 23, 2004·The Journal of Clinical Endocrinology and Metabolism·Dana EricksonJohannes D Veldhuis
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Amutha Selvamani, Farida Sohrabji
May 12, 2007·Pituitary·Mark Sherlock, Andrew A Toogood
Aug 31, 2012·Pituitary·Ilan Shimon, Ariel Barkan
Dec 1, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·John W SchmidtLinda S Kim
Mar 6, 2007·Endocrinology and Metabolism Clinics of North America·Udo J Meinhardt, Ken K Y Ho
Oct 28, 2016·Endocrine·Felipe H DuarteMarcello D Bronstein
Oct 4, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Emily A Southmayd, Mary Jane De Souza
Dec 20, 2008·Clinical Endocrinology·Christina I MessiniIoannis E Messinis
Jul 14, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R HannonR Eastell
Jun 29, 2006·The Journal of Clinical Endocrinology and Metabolism·Johannes D VeldhuisCyril Y Bowers
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·A G RenehanS M Shalet
Aug 9, 2001·Endocrine Reviews·W M DrakeS M Shalet
Dec 23, 2004·The Journal of Clinical Endocrinology and Metabolism·Xiao-Dan QuChristina Wang
May 6, 2005·The Journal of Clinical Endocrinology and Metabolism·Eija KellokoskiSohvi Hörkkö
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·S M AndersonJ D Veldhuis
Jan 5, 2006·American Journal of Physiology. Endocrinology and Metabolism·Thomas MünzerMarc R Blackman
Dec 3, 1999·Clinical Endocrinology·K Landin-WilhelmsenB A Bengtsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.